Sun Pharmaceuticals acquires Concert for $576M

The latest stories trending on MedCity News.

Editor's Pick

Top Story Sun Pharma Strikes $576M Deal to Get Hair Loss Drug to Rival Lilly, Pfizer Meds Sun Pharmaceuticals is acquiring Concert Pharmaceuticals, a biotech whose lead program has positive data from two late-stage clinical trials in alopecia areata. The deal gives Sun Pharma a drug candidate that could match up against hair loss drugs from two big pharmaceutical companies. Do You Want $20K in Advertising for Your Startup? Application Deadline is January 30th   There is no fee to apply. Only companies funded from 2018-2022 (no more than five years ago), and that have raised a seed funding round will be considered. Startups can apply to only one track. Startups must be registered for the conference in order to participate in the pitch contest. There are five tracks and each track will feature six finalists. Application Deadline: January 30, 2023. Applications will be reviewed by investment professionals and selections announced on Feb. 21, 2023.   Apply Now

Featured News

StartUPDATES: New Developments from Healthcare Startups Check out news from BioMEMS Diagnostics, Rx Redefined, Ferrum Health and Avanlee Care. FDA Rejects Eli Lilly Alzheimer's Drug, Asks for More Data From Ongoing Study Eli Lilly's accelerated approval application for its Alzheimer's disease drug has fallen short. The company said the FDA is asking for data from more patients—results that must come from a larger study that's underway but won't report data until later this year. 25 Shocking Statistics That Keep Healthcare Executives Up at Night History has shown that while healthcare is more open to adopting technology to improve outcomes, […] Abbott Enters TAVI Device Market Dominated by Edwards, Medtronic Abbott recently earned FDA approval for its latest transcatheter aortic valve implantation (TAVI) system, which is named Navitor. Abbott will have to fight for its place the U.S. TAVI device space, as the systems made by Edwards and Medtronic have a steadfast command of the market share. Posterity Health Raises $7.5M as Employers Expand Male Fertility Benefits Posterity Health recently raised $7.5 million in an oversubscribed funding round. The startup's digital male fertility platform offers a combination of virtual visits, at-home diagnostics and in-person consultations to assess and improve patients' fertility status. The Rise of Interest & Investment in Women's Health Women have been dismissed and neglected for centuries: any investment and innovation in this space can make an outsized impact: keeping women and their families healthy, aiding research and development, and eliminating the gender bias against women and their healthcare that has persisted since Ancient Greece. Point32Health Taps Included Health for LGBTQ+ Care Point32Health will now be able offer members access to LGBTQ+ Health, Included Health's navigation and advocacy program for LGBTQ+ members. These members will have access to a care team led by LGBTQ+ care coordinators, who can help them find in-network, gender-affirming providers. They can also be connected to support groups and receive education on medical and legal issues.

Resources

Your Complimentary 2023 HIPAA Checklist Begin 2023 on the right compliance foot. This HIPAA checklist is the best tool to assess your current HIPAA efforts.   Download Now

MedCity News • 611 Broadway • New York, NY unsubscribe